{"nct_id":"NCT01305551","title":"BE Study of the Fixed Dose Combination of 5 mg Saxagliptin and 500 mg Metformin HCl XR Tablet Relative to a 5 mg Saxagliptin (Onglyza™) Tablet and a 500 mg Metformin HCl XR (Glifage® XR Marketed in Brazil by Merck S.A.) Tablet Co-Administered to Healthy Subjects in the Fasted and Fed States","status":"WITHDRAWN","status_verified_date":"2014-06","start_date":"2011-03","start_date_type":null,"primary_completion_date":"2011-03","primary_completion_date_type":"ACTUAL","completion_date":"2011-03","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["AZN"]}